Andrew Jallouk, MD, PhD
Researcher Spotlight: Andrew Jallouk, MD, PhD VANDERBILT UNIVERSITY MEDICAL CENTER Errol M. Cook Memorial Scholar…
Tag CAR T-cell
Alexander Boardman, MD
Researcher Spotlight: Alexander Boardman, MD MEMORIAL SLOAN KETTERING Dobosh Family Scholar Treatment of lymphoma has…
Ajilan Al Zaki, MD, PhD
Researcher Spotlight: Ajilan Al Zaki, MD, PhD MD ANDERSON CANCER CENTER Chimeric antigen receptor (CAR)…
Alexandre Vinaud Hirayama, MD
Researcher Spotlight: Alexandre Vinaud Hirayama, MD Fred Hutchinson Cancer Research Center Chimeric antigen receptor (CAR)…
Marco Ruella, MD
Researcher Spotlight: Marco Ruella, MD Perelman School of Medicine, University of Pennsylvania Chimeric antigen receptor…
CAR-T Cell Therapy and Other Novel Therapies for Lymphoma
In 2015, Stacy-Humphrie's diffuse large B-Cell lymphoma (DLBCL) relapsed and she was faced with a tough decision - to follow the standard of care and receive a stem cell transplant, or opt for a new treatment called CAR-T cell therapy which at the time, was still in the clinical trial phase.
Natalie Grover, MD
Researcher Spotlight: Natalie Grover, MD The University of North Carolina at Chapel Hill Although a…
Yong Gu Lee, PhD
Researcher Spotlight: Yong Gu Lee, PhD The Trustees of the University of Pennsylvania Diffuse…
Raghuveer Ranganathan, MD
Researcher Spotlight: Raghuveer Ranganathan, MD University of North Carolina, Chapel Hill Though CAR T-cell therapy…
Irene Scarfo, PhD
Researcher Spotlight: Irene Scarfo, PhD Massachusetts General Hospital The majority of chimeric antigen receptor (CAR)…
Stay informed with news, alerts and other resources.
